Renewing Upstaza (Kebilidi) Approval with Blue Cross Blue Shield of Texas: 2025 Requirements & Timeline
Answer Box: Upstaza (Kebilidi) gene therapy for AADC deficiency requires annual prior authorization renewal with Blue Cross Blue Shield of Texas 30-60 days before expiration. Start 90 days early to prevent coverage gaps. Required documents include clinical assessments, motor milestone evaluations, and 12-month outcome data. Submit through Availity Authorization &